Chemotherapy and Targeted Therapy

Supreme Court Ruling Protects “Skinny Labeling,” Dealing Blow to Brand-Name Pharmaceutical Patent Strategies

• Chemotherapy and Targeted Therapy

Supreme Court Ruling Protects “Skinny Labeling,” Dealing Blow to Brand-Name Pharmaceutical Patent Strategies

Nana Muazin June 6, 2026

By [Your Name/Journalistic Staff] June 5, 2026 In a landmark decision that promises to reshape the landscape...

Read More Read more about Supreme Court Ruling Protects “Skinny Labeling,” Dealing Blow to Brand-Name Pharmaceutical Patent Strategies

The Treasure Trove in the Trash: How Nonprofits are Rescuing Shelved Rare Disease Therapies

• Chemotherapy and Targeted Therapy

The Treasure Trove in the Trash: How Nonprofits are Rescuing Shelved Rare Disease Therapies

Reynand Wu June 6, 2026

In the high-stakes world of pharmaceutical development, the graveyard of "shelved" assets is vast. According to Annette...

Read More Read more about The Treasure Trove in the Trash: How Nonprofits are Rescuing Shelved Rare Disease Therapies

Lundbeck’s Bocunebart: A New Frontier in the Battle Against Refractory Migraine

• Chemotherapy and Targeted Therapy

Lundbeck’s Bocunebart: A New Frontier in the Battle Against Refractory Migraine

Lina Hope June 5, 2026 0

In the high-stakes world of pharmaceutical development, few therapeutic areas are as crowded yet as persistently underserved...

Read More Read more about Lundbeck’s Bocunebart: A New Frontier in the Battle Against Refractory Migraine

The Race Against Time: CEPI Fast-Tracks Three Vaccine Candidates to Combat Bundibugyo Ebolavirus

• Chemotherapy and Targeted Therapy

The Race Against Time: CEPI Fast-Tracks Three Vaccine Candidates to Combat Bundibugyo Ebolavirus

Asep Darmawan June 5, 2026 0

In a decisive move to curb a burgeoning public health crisis, the Coalition for Epidemic Preparedness Innovations...

Read More Read more about The Race Against Time: CEPI Fast-Tracks Three Vaccine Candidates to Combat Bundibugyo Ebolavirus

ADC Therapeutics Faces Market Reckoning as Clinical Success is Overshadowed by Safety Concerns

• Chemotherapy and Targeted Therapy

ADC Therapeutics Faces Market Reckoning as Clinical Success is Overshadowed by Safety Concerns

Nana Wu June 5, 2026 0

In the high-stakes world of oncology drug development, the line between a breakthrough and a setback is...

Read More Read more about ADC Therapeutics Faces Market Reckoning as Clinical Success is Overshadowed by Safety Concerns

Race Against Time: CEPI Accelerates Global Response to Bundibugyo Ebolavirus Outbreak

• Chemotherapy and Targeted Therapy

Race Against Time: CEPI Accelerates Global Response to Bundibugyo Ebolavirus Outbreak

Layla Zulfa June 5, 2026 0

In a decisive move to curb a burgeoning public health crisis, the Coalition for Epidemic Preparedness Innovations...

Read More Read more about Race Against Time: CEPI Accelerates Global Response to Bundibugyo Ebolavirus Outbreak

Racing Against Time: CEPI Fast-Tracks Three Vaccine Candidates to Combat BDBV Outbreak

• Chemotherapy and Targeted Therapy

Racing Against Time: CEPI Fast-Tracks Three Vaccine Candidates to Combat BDBV Outbreak

Azzam Bilal Chamdy June 5, 2026 0

The Coalition for Epidemic Preparedness Innovations (CEPI) has launched an urgent, multi-pronged initiative to develop a vaccine...

Read More Read more about Racing Against Time: CEPI Fast-Tracks Three Vaccine Candidates to Combat BDBV Outbreak

Market Volatility Hits ADC Therapeutics as Confirmatory Trial Raises Safety Alarms

• Chemotherapy and Targeted Therapy

Market Volatility Hits ADC Therapeutics as Confirmatory Trial Raises Safety Alarms

Nana Muazin June 4, 2026 0

By Financial News Desk Shares of Switzerland-based biotechnology firm ADC Therapeutics plummeted by more than 50% on...

Read More Read more about Market Volatility Hits ADC Therapeutics as Confirmatory Trial Raises Safety Alarms

FDA Commissioner Marty Makary Resigns Amidst Administrative Pressure and Policy Turmoil

• Chemotherapy and Targeted Therapy

FDA Commissioner Marty Makary Resigns Amidst Administrative Pressure and Policy Turmoil

Siti Muinah June 4, 2026 0

WASHINGTON, D.C. — In a development that signals a profound shift in the regulatory landscape of the...

Read More Read more about FDA Commissioner Marty Makary Resigns Amidst Administrative Pressure and Policy Turmoil

Betting on Resistance: Barcelona’s Ona Therapeutics Secures $86.6 Million to Revolutionize ADC Oncology

• Chemotherapy and Targeted Therapy

Betting on Resistance: Barcelona’s Ona Therapeutics Secures $86.6 Million to Revolutionize ADC Oncology

Nana Wu June 4, 2026 0

In a significant boost for the European biotechnology landscape, Barcelona-based Ona Therapeutics has successfully closed an $86.6...

Read More Read more about Betting on Resistance: Barcelona’s Ona Therapeutics Secures $86.6 Million to Revolutionize ADC Oncology